Ritesh Jain appointed CFO of Krebs Biochemicals and Industries
People

Ritesh Jain appointed CFO of Krebs Biochemicals and Industries

He is a Chartered Accountant with more than 19 years of extensive experience

  • By IPP Bureau | February 04, 2023
Krebs Biochemicals and Industries Limited has appointed Ritesh Jain as Chief Financial Officer (CFO) effective from February 3, 2023. 
 
Ritesh Jain is a Chartered Accountant with more than 19 years of extensive experience in accounts finalization, direct & indirect taxation, audit — Statutory & internal, management reporting and analysis, project profitability and variance analytics, preparation of budget and variance analysis, direct taxation & GST and general accounting & reporting. In addition, Ritesh Jain has proven skills in managing service delivery, client relationships and transformation. Before that he was associated with Nahar Builders. 
 
Established in 1991, Krebs undertakes both contract manufacturing for large pharmaceutical and multinational companies and develops products for sale in global markets. The company is headquartered in Hyderabad, India with manufacturing plants in Nellore and Vizag, India.  
 
The company has expertise in the areas of chemical synthesis, fermentation and enzymatic technologies along with a focus on cost and quality makes Krebs a logical partner for the development and supply of products made using one or more of these technologies.

Upcoming E-conference

Other Related stories

Startup

Digitization